365 related articles for article (PubMed ID: 34382360)
1. Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles.
Evers MJW; van de Wakker SI; de Groot EM; de Jong OG; Gitz-François JJJ; Seinen CS; Sluijter JPG; Schiffelers RM; Vader P
Adv Healthc Mater; 2022 Mar; 11(5):e2101202. PubMed ID: 34382360
[TBL] [Abstract][Full Text] [Related]
2. Synergistic siRNA Loading of Extracellular Vesicles Enables Functional Delivery into Cells.
Roerig J; Mitrach F; Schmid M; Hause G; Hacker MC; Wölk C; Schulz-Siegmund M
Small Methods; 2022 Dec; 6(12):e2201001. PubMed ID: 36284470
[TBL] [Abstract][Full Text] [Related]
3. Production of Extracellular Vesicles Loaded with Therapeutic Cargo.
Lamichhane TN; Jay SM
Methods Mol Biol; 2018; 1831():37-47. PubMed ID: 30051423
[TBL] [Abstract][Full Text] [Related]
4. Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles.
O'Loughlin AJ; Mäger I; de Jong OG; Varela MA; Schiffelers RM; El Andaloussi S; Wood MJA; Vader P
Mol Ther; 2017 Jul; 25(7):1580-1587. PubMed ID: 28392161
[TBL] [Abstract][Full Text] [Related]
5. Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems.
Piffoux M; Silva AKA; Wilhelm C; Gazeau F; Tareste D
ACS Nano; 2018 Jul; 12(7):6830-6842. PubMed ID: 29975503
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles as drug delivery systems: lessons from the liposome field.
van der Meel R; Fens MH; Vader P; van Solinge WW; Eniola-Adefeso O; Schiffelers RM
J Control Release; 2014 Dec; 195():72-85. PubMed ID: 25094032
[TBL] [Abstract][Full Text] [Related]
7. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design.
Kooijmans SAA; de Jong OG; Schiffelers RM
Adv Drug Deliv Rev; 2021 Jun; 173():252-278. PubMed ID: 33798644
[TBL] [Abstract][Full Text] [Related]
8. Liposomes and Extracellular Vesicles as Drug Delivery Systems: A Comparison of Composition, Pharmacokinetics, and Functionalization.
van der Koog L; Gandek TB; Nagelkerke A
Adv Healthc Mater; 2022 Mar; 11(5):e2100639. PubMed ID: 34165909
[TBL] [Abstract][Full Text] [Related]
9. On the use of liposome controls in studies investigating the clinical potential of extracellular vesicle-based drug delivery systems - A commentary.
Johnsen KB; Gudbergsson JM; Duroux M; Moos T; Andresen TL; Simonsen JB
J Control Release; 2018 Jan; 269():10-14. PubMed ID: 29126999
[TBL] [Abstract][Full Text] [Related]
10. Polymer-Coated Extracellular Vesicles for Selective Codelivery of Chemotherapeutics and siRNA to Cancer Cells.
Jhan YY; Palou Zuniga G; Singh KA; Gaharwar AK; Alge DL; Bishop CJ
ACS Appl Bio Mater; 2021 Feb; 4(2):1294-1306. PubMed ID: 35014481
[TBL] [Abstract][Full Text] [Related]
11. Milk-derived Extracellular Vesicles for Therapeutic Delivery of Small Interfering RNAs.
Matsuda A; Patel T
Methods Mol Biol; 2018; 1740():187-197. PubMed ID: 29388145
[TBL] [Abstract][Full Text] [Related]
12. Exogenous DNA Loading into Extracellular Vesicles via Electroporation is Size-Dependent and Enables Limited Gene Delivery.
Lamichhane TN; Raiker RS; Jay SM
Mol Pharm; 2015 Oct; 12(10):3650-7. PubMed ID: 26376343
[TBL] [Abstract][Full Text] [Related]
13. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
[TBL] [Abstract][Full Text] [Related]
14. Generation of Hybrid Extracellular Vesicles by Fusion with Functionalized Liposomes.
Piffoux M; Silva AKA; Gazeau F; Tareste D
Methods Mol Biol; 2022; 2473():385-396. PubMed ID: 35819777
[TBL] [Abstract][Full Text] [Related]
15. Gene knockdown in HaCaT cells by small interfering RNAs entrapped in grapefruit-derived extracellular vesicles using a microfluidic device.
Itakura S; Shohji A; Amagai S; Kitamura M; Takayama K; Sugibayashi K; Todo H
Sci Rep; 2023 Feb; 13(1):3102. PubMed ID: 36813850
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicle-Based Hybrid Systems for Advanced Drug Delivery.
Rodríguez DA; Vader P
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214000
[TBL] [Abstract][Full Text] [Related]
17. Natural or Synthetic RNA Delivery: A Stoichiometric Comparison of Extracellular Vesicles and Synthetic Nanoparticles.
Murphy DE; de Jong OG; Evers MJW; Nurazizah M; Schiffelers RM; Vader P
Nano Lett; 2021 Feb; 21(4):1888-1895. PubMed ID: 33570966
[TBL] [Abstract][Full Text] [Related]
18. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
19. Preparation and Isolation of siRNA-Loaded Extracellular Vesicles.
Vader P; Mäger I; Lee Y; Nordin JZ; Andaloussi SE; Wood MJ
Methods Mol Biol; 2017; 1545():197-204. PubMed ID: 27943216
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicle Loading Via pH-Gradient Modification.
Kronstadt SM; Jay SM; Jeyaram A
Methods Mol Biol; 2022; 2504():231-239. PubMed ID: 35467291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
